Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 12:03:47 2024-03-27 pm EDT 5-day change 1st Jan Change
0.635 USD +15.45% Intraday chart for Minerva Surgical, Inc. +7.63% -45.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index CI
Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index CI
North American Morning Briefing : Stock Futures Edge Up to Start the Week DJ
Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M MT
Minerva Surgical, Inc. cancelled the transaction announced on September 28, 2023 CI
Minerva Surgical, Inc. announced that it expects to receive $20 million in funding from Accelmed Partners CI
Transcript : Minerva Surgical, Inc., Q2 2023 Earnings Call, Aug 02, 2023
Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13.4M MT
Minerva Surgical, Inc. Provides Earnings Guidance for the Fiscal Year 2023 CI
Minerva Surgical, Inc. Announces Resignation of Ross A. Jaffe from the Board and from the Compensation Committee of the Board CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Growth Index CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Growth Index CI
Sector Update: Health Care Stocks Decline MT
Sector Update: Health Care Stocks Lower on Wednesday Afternoon MT
Minerva Surgical Gets US Patent for Medical System for Tissue Extraction, Resection; Shares Jump MT
Wall Street Set to Open Lower as Investors Await Progress on Debt-Ceiling Talks Ahead of Fed Minutes Release MT
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release MT
Top Premarket Gainers MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $1 From $5, Keeps Overweight Rating MT
Transcript : Minerva Surgical, Inc., Q1 2023 Earnings Call, May 02, 2023
Minerva Surgical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart Minerva Surgical, Inc.
More charts
Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
More about the company
  1. Stock
  2. Equities
  3. Stock Minerva Surgical, Inc. - OTC Markets
  4. News Minerva Surgical, Inc.
  5. Minerva Surgical Swings to Q4 Profit, Revenue Edges Higher Over Year-Ago Levels